3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Monocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Teratoma
1
Solid Tumors
1
Sarcoma, Myeloid
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, AIDS-Related
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Choriocarcinoma
1
Carcinoma, Embryonal
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Vincristine
9
Cyclophosphamide
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Irinotecan
6
Biopsy
5
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Dactinomycin
4
fludarabine
3
Vinorelbine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
pegylated granulocyte colony-stimulating factor
×
90 days
×
Clear all
No trials found.